UK startup Healx to begin clinical trial on repositioned drug for Fragile X syndrome

16:46 20.10.2021
There are currently no approved cures for Fragile X syndrome – the most common cause of inherited intellectual disability. At the moment, the treatments are designed to manage symptoms, from anxiety to OCD or in rare cases, seizures. But a new clinical trial is soon to be underway at a UK startup.  On Wednesday, drug discovery […]...
Теги: Стартап
  262